Leiss, S.M.* et al. Analysis of radiation oncology integration within general practitioners' daily patient care: A cross-sectional survey in Germany. Strahlenther. Onkol. 201, 723-731 (2025)
Piroth, M.D.* et al. Implant-based reconstruction and adjuvant radiotherapy in breast cancer patients-current status and DEGRO recommendations. Strahlenther. Onkol. 201, 353-367 (2025)
Trommer, M.* et al. Balancing barriers: Family, career, and gender equality in radiation oncology and radiation research-An interdisciplinary prospective survey among the young workforce. Strahlenther. Onkol., DOI: 10.1007/s00066-025-02402-2 (2025)
Trommer, S.* et al. Tumor volume change at radiation boost planning to estimate the response to chemoradiotherapy in stage III unresectable NSCLC (TORCH): A multicenter retrospective observational study. Strahlenther. Onkol., DOI: 10.1007/s00066-025-02374-3 (2025)
Vorbach, S.M.* et al. Contouring in transition: Perceptions of AI-based autocontouring by radiation oncologists and medical physicists in German-speaking countries. Strahlenther. Onkol., DOI: 10.1007/s00066-025-02403-1 (2025)
Warmbrunn, J.* et al. Influence of radiotherapy on cardiac implantable devices and leads-a single-institution analysis and critical evaluation of current guidelines. Strahlenther. Onkol. 201, 463-471 (2025)
Borm, K.J.* et al. DEGRO guideline for personalized radiotherapy of brain metastases and leptomeningeal carcinomatosis in patients with breast cancer. Strahlenther. Onkol. 200, 259-275 (2024)
Erdur, A.C.* et al. Deep learning for autosegmentation for radiotherapy treatment planning: State-of-the-art and novel perspectives. Strahlenther. Onkol., DOI: 10.1007/s00066-024-02262-2 (2024)
Marschner, S. et al. Adjuvant (chemo)radiotherapy for patients with head and neck cancer: Can comorbidity risk scores predict outcome? Strahlenther. Onkol., DOI: 10.1007/s00066-024-02282-y (2024)
Janssen, S.* et al. Mobile applications in radiation oncology-current choices and future potentials. Strahlenther. Onkol. 199, 337-349 (2023)
Waltenberger, M.* et al. Radiotherapy concepts for spinal metastases-results from an online survey among radiation oncologists of the German Society for Radiation Oncology. Strahlenther. Onkol. 200, 159-174 (2023)
Wittmann, A.* et al. Chronic inflammatory effects of in vivo irradiation of the murine heart on endothelial cells mimic mechanisms involved in atherosclerosis. Strahlenther. Onkol. 199, 1214-1224 (2023)
Bernhardt, D.* et al. DEGRO practical guideline for central nervous system radiation necrosis part 2: Treatment. Strahlenther. Onkol. 198, 971-980 (2022)
Bernhardt, D.* et al. DEGRO practical guideline for central nervous system radiation necrosis part 1: Classification and a multistep approach for diagnosis. Strahlenther. Onkol. 198, 873-883 (2022)
Kraus, K.M. & Combs, S.E. Stereotaktisch
 ablative Strahlentherapie für operable nichtkleinzellige 
Bronchialkarzinome in Stadium I (überarbeitete STARS-Studie): 
Langzeitergebnisse einer einarmigen, prospektiven Studie mit Vergleich 
zur Operation. Strahlenther. Onkol. 198, 214-218 (2022)
Vogel, M.M. ; Kessel, C.* ; Eitz, K.A. & Combs, S.E. Coronavirus disease 2019 and radiation oncology—survey on the impact of the severe acute respiratory syndrome coronavirus 2 pandemic on health care professionals in radiation oncology. Strahlenther. Onkol. 198, 346-353 (2022)
Dapper, H.* et al. Integration of radiation oncology teaching in medical studies by German medical faculties due to the new licensing regulations: An overview and recommendations of the consortium academic radiation oncology of the German Society for Radiation Oncology (DEGRO). Strahlenther. Onkol., DOI: 10.1007/s00066-021-01861-7 (2021)
Krug, D.* et al. Moderate hypofractionation remains the standard of care for whole-breast radiotherapy in breast cancer: Considerations regarding FAST and FAST-Forward. Strahlenther. Onkol. 197, 269-280 (2021)
Krug, D.* et al. Innovative radiation oncology Together – Precise, Personalized, Human: Vision 2030 for radiotherapy & radiation oncology in Germany. Strahlenther. Onkol., DOI: 10.1007/s00066-021-01843-9 (2021)
Krug, D.* et al. Correction to: Innovative radiation oncology Together-Precise, Personalized, Human. Strahlenther. Onkol., DOI: 10.1007/s00066-021-01869-z (2021)
Lapa, C.* et al. Value of PET imaging for radiation therapy. Strahlenther. Onkol. 197, 1-23 (2021)
Schiller, K.* & Combs, S.E. Effektivität
 einer sequenziellen versus einer simultanen Radiochemotherapie oder 
alleinigen Radiotherapie bei der adjuvanten Behandlung des 
Zervixkarzinoms nach Hysterektomie. Strahlenther. Onkol. 197, 746-748 (2021)
Vogel, M.M. et al. Patterns of care for prostate cancer radiotherapy—results from a survey among German-speaking radiation oncologists. Strahlenther. Onkol. 197, 962-970 (2021)
Bartzsch, S. et al. Micro-radiation Therapy on a compact Radiation Source. Strahlenther. Onkol. 196, 1, S207-S207 (2020)
Bernhardt, D.* & Combs, S.E. Zielvolumenreduktion durch 18F-FDG-PET/CT-basierte
 „involved field“ Bestrahlung beim fortgeschrittenen NSCLC 
möglicherweise neuer Standard: Ergebnisse der PET-Plan-Studie. Strahlenther. Onkol. 196, 743-746 (2020)
Bicher, S. et al. The protection of healthy tissues in radiation therapy by spatial fractionation. Strahlenther. Onkol. 196, S189-S189 (2020)
Borm, K.J.* et al. Variability in lymph node irradiation in patients with breast cancer-results from a multi-center survey in German-speaking countries. Strahlenther. Onkol. 196, 15–22 (2020)
Borm, K.J.* et al. Effect of hypofractionation on the incidental axilla dose during tangential field radiotherapy in breast cancer. Strahlenther. Onkol. 196, 771–778 (2020)
Borm, K.J. et al. Adjuvant Irradiation of the internal Mammary Lymph Nodes of Patients with Breast Cancer. How high is the additional Toxicity when Using modern Radiation Techniques? Strahlenther. Onkol. 196, 1, S139-S139 (2020)
Combs, S.E. & Atkinson, M.J. Happy birthday, Klaus-Rudiger! Heartfelt appreciation on the occasion of the 80th birthday of Professor Klaus-Rudiger Trott. Strahlenther. Onkol. 196, 747–748 (2020)
Dapper, H.* et al. Dosimetric comparison of organs at risk using different contouring guidelines for definition of the clinical target volume in anal cancer. Strahlenther. Onkol. 196, 368–375 (2020)
Dapper, H.* et al. Radiation oncology as part of medical education—current status and possible digital future prospects. Strahlenther. Onkol., DOI: 10.1007/s00066-020-01712-x (2020)
Devecka, M.* et al. Analysis of the local recurrence pattern after radical prostatectomy in PSMA-PET-based radiotherapy planning. Strahlenther. Onkol. 196, S92-S92 (2020)
Dobiasch, S. et al. High-Precision Radiotherapy in clinically relevant Tumor Mouse Models to implement personalized clinical Trials in Radiooncology. Strahlenther. Onkol. 196, 1, S7-S7 (2020)
Drexler, G.A. et al. Patient-derived HNSCC cell lines and subclones reflect inter- and intra-tumoral heterogeneity regarding various molecular and phenotypic aspects. Strahlenther. Onkol. 196, 1, S49-S50 (2020)
Eckert, D.* et al. Characterization of serum-derived extracellular vesicles from leukaemic patients to identify leukaemic and radiation biomarkers. Strahlenther. Onkol. 196, S186-S187 (2020)
Fleischmann, D.F.* et al. Risk Stratification of Glioblastoma Patients using Blood Plasma Samples. Strahlenther. Onkol. 196, 1, S119-S120 (2020)
Hansel, C.* et al. Radiation-induced senescence as potential target for normal tissue protection. Strahlenther. Onkol. 196, 1, S184-S184 (2020)
Hofmann, C.* ; Borm, K.J.* ; Oechsner, M.* ; Duesberg, M.* & Combs, S.E. Internal Mammary Irradiation Technique in Patients with Breast Cancer. What is the Influence of CTV-PTV Safety Margins? Strahlenther. Onkol. 196, 1, S140-S141 (2020)
Huber, K.* et al. Characterization of radiation-induced Normal Tissue Reactions in a Head and Neck Tumor Patient Collective. Strahlenther. Onkol. 196, S191-S191 (2020)
Kern, J. et al. Identification of Biomarkers for the Prediction of Radiation Sensitivity in ductal Adenocarcinoma of the Pancreas by means of Gene Set Enrichment Analysis. Strahlenther. Onkol. 196, 1, S193-S193 (2020)
Kirstein, A. ; Schilling, D. ; Combs, S.E. & Schmid, T.E. Influence of MGMT expression on the radiation sensitivity of human glioblastoma cell lines. Strahlenther. Onkol. 196, 1, S185-S185 (2020)
Kraus, K.M.* ; Oechsner, M.* ; Wilkens, J.J. & Combs, S.E. Stereotactic Irradiation of peripheral Lung Tumors using Respiratory Gating: Correlation between PTV Reduction, Tumor Movement and Volume Dose. Strahlenther. Onkol. 196, 1, S13-S13 (2020)
Kurrumeli, D.* et al. An easy way to determine bone mineral density and predict pelvic insufficiency fractures in patients treated with radiotherapy for cervical cancer. Strahlenther. Onkol. 197, 487-493 (2020)
Lang, D.M. et al. Soft tissue sarcoma contouring based on planning CTs using deep learning. Strahlenther. Onkol. 196, 1, S33-S33 (2020)
Maier, S.H.* et al. Combination of EGFR-specific, 5-FU-bearing Aptamers with Radiation: Characterization in in vitro Models of Squamous Cell Carcinoma of the Head and Neck Region (HNSCC). Strahlenther. Onkol. 196, 1, S188-S188 (2020)
Matuschek, C.* et al. Measures of infection prevention and incidence of SARS-CoV-2 infections in cancer patients undergoing radiotherapy in Germany, Austria and Switzerland. Strahlenther. Onkol. 196, 1068-1079 (2020)
Muench, S.* ; Devecka, M.* ; Oechsner, M.* ; Friess, H.* & Combs, S.E. Combined neoadjuvant/definitive Chemoradiotherapy in Patients with Oesophageal carcinoma and irresectable Lymph Node Metastases. Strahlenther. Onkol. 196, 1, S152-S152 (2020)
Münch, S.* et al. Impact of F-18-FDG-PET/CT on the identification of regional lymph node metastases and delineation of the primary tumor in esophageal squamous cell carcinoma patients. Strahlenther. Onkol. 196, 787-794 (2020)
Mutlu, S.* et al. Intrinsic radioresistance and intra-tumoral heterogeneity in HNSCC. Strahlenther. Onkol. 196, 1, S189-S190 (2020)
Peeken, J.C. et al. Development and Validation of a CT-based Radiomic Model for the Detection of Lymph Node Metastases in Patients with recurrent Prostate Cancer. Strahlenther. Onkol. 196, 1, S28-S29 (2020)
Peeken, J.C. et al. Improved survival prediction in patients with soft tissue sarcoma through the application of deep learning. Strahlenther. Onkol. 196, 1, S33-S34 (2020)
Rödel, F.* et al. Low-dose radiation therapy for COVID-19 pneumopathy: What is the evidence? Strahlenther. Onkol. 196, 679-682 (2020)
Sage, E.K.* et al. Stereotactic Body Radiotherapy (SBRT) for the Treatment of oligometastatic Prostate Carcinoma. Strahlenther. Onkol. 196, 1, S160-S161 (2020)
Salfelder, M.A.* et al. Prospective evaluation of multitarget treatment of pediatric patients with helical intensity-modulated radiotherapy. Strahlenther. Onkol. 196, 1103–1115 (2020)
Schmid, T.E. et al. Proton minibeam radiation therapy-an innovative strategy in cancer treatment. Strahlenther. Onkol. 196, S109-S109 (2020)
Schmidt-Hegemann, N.-S.* et al. DNA copy number and DNA methylome analysis of primary prostate cancer and pathologic lymph node metastases in patients with low and high Gleason score. Strahlenther. Onkol. 196, 1, S158-S159 (2020)
Schrickel, F. et al. Heterogeneous invasion capacity of patient-derived primary glioblastoma multiforme cells. Strahlenther. Onkol. 196, 1, S109-S110 (2020)
Vogel, M.M. et al. Toxicity of PSMA-PET-based Salvage Radiotherapy with a simultaneous integrated Boost for Patients with Recurrence of Prostate Cancer after radical Prostatectomy. Strahlenther. Onkol. 196, S160-S160 (2020)
Waltenberger, M.* ; Kessel, K.A. ; Devecka, M.* ; Peeken, J.C. & Combs, S.E. Stereotactic body radiation therapy of spine metastases using a simultaneous integrated boost concept-evaluation of effectiveness and toxicity. Strahlenther. Onkol. 196, 1, S16-S16 (2020)
Al Bazaz, M.* ; Selmansberger, M. ; Engenhart-Cabillic, R.* ; Lauber, K.* & Schoetz, U.* Tumor stem cell factor CD44v6 influences G2 arrest and radiation sensitivity in S phase after irradiation. Strahlenther. Onkol. 195, S127-S127 (2019)
Asadpour, R.* ; Pigorsch, S.U.* & Combs, S.E. Unexpected discontinuations in patients undergoing radiotherapy. Strahlenther. Onkol. 195, S134-S134 (2019)
Bicher, S. et al. Biologically inspired nanoparticles as tools for the protection of healthy tissues in radiotherapy. Strahlenther. Onkol. 195, S165-S165 (2019)
Borm, K.J.* et al. The influence of hypofractionation on the incidental irradiation of the axillary lymphatic pathways of patients with breast cancer. Strahlenther. Onkol. 195, S21-S21 (2019)
Dapper, H.* et al. Have we achieved optimal Recommendations for the Target Volume Definition for Patients with Anal Cancer? A PET-based Analysis of the initial Lymph Node Distribution in Patients with Anal Cancer. Strahlenther. Onkol. 195, S9-S9 (2019)
Diehl, C. et al. Neoadjuvant radiotherapy (N-RT) for intracebral metastases of solid tumors (NepoMUC): A phase I dose escalation trial. Strahlenther. Onkol. 195, S117-S117 (2019)
Dobiasch, S. et al. Histopathological validation of the accuracy of high-precision stereotactic irradiation in an orthotopic pancreatic tumor mouse model. Strahlenther. Onkol. 195, S172-S172 (2019)
Eidemüller, M. ; Holmberg, E.* ; Lundell, M.* & Karlsson, P.* Increased risk of breast cancer from radiation in the presence of familial breast cancer history: Results from the Swedish hemangioma cohort and implications for breast cancer radiotherapy. Strahlenther. Onkol. 195, S81-S81 (2019)
Fischer, J.C.* et al. No improved Regeneration after radiogenic and immunopathogenic Tissue Damage by Type III Interferon Activation. Strahlenther. Onkol. 195, S166-S166 (2019)
Gerhardt, A.S.* et al. Simulation of the Influence of Rotational Errors on the Dose in PTV and Risk Organs during the Storage for cranial Radiotherapy. Strahlenther. Onkol. 195, S108-S108 (2019)
Hess J. et al. A five-microRNA-signature predicts recurrence and survival in HPV-negative HNSCC. Strahlenther. Onkol. 195, S25-S25 (2019)
Kern J.* et al. Identification of Biomarkers for the Determination of individual Radiosensitivity in Patients with pancreatic ductal Adenocarcinoma. Strahlenther. Onkol. 195, S172-S172 (2019)
Kessel, C. et al. A five-year report on the MSc radiation biology at the technical University of Munich (TUM). Strahlenther. Onkol. 195, S192-S192 (2019)
Kessel, K.A. et al. Influence of PET imaging during the radiotherapy planning on the survival of meningioma patients. Strahlenther. Onkol. 195, S113-S113 (2019)
Kessel, K.A. et al. Is fractional stereotactic radiation therapy (FSRT) superior to radiosurgery (RC) for the treatment of resection hollow in patients with brain metastases? Strahlenther. Onkol. 195, S113-S114 (2019)
Kessel, K.A. ; Weber, W.* ; Zimmer, C.* ; Meyer, B.* & Combs, S.E. Development of a prognostic score for the outcome after resection and radiotherapy in patients with high-grade meningioma (WHO II/III). Strahlenther. Onkol. 195, S34-S34 (2019)
Kessler, C.* et al. Characterization of the radiation response of different patient-derived organoids of pancreatic cancer. Strahlenther. Onkol. 195, S41-S42 (2019)
Kirstein, A. et al. Influence of MGMT expression on the radiation response in different Glioblastoma multiforme cell lines. Strahlenther. Onkol. 195, S162-S163 (2019)
Klymenko, O. et al. Patient-derived HNSCC cell lines and subclones reflect inter- and intra-tumoral heterogeneity regarding genomic copy number alterations and radiation response. Strahlenther. Onkol. 195, S75-S76 (2019)
Kokowski, K.* et al. Radiochemotherapy combined with NK cell transfer followed by second-line PD-1 inhibition in apatient with NSCLC stage IIIb inducing long-term tumor control: Acase study. Strahlenther. Onkol. 195, 352-361 (2019)
Kraus, K.M.* & Combs, S.E. Zweitmalignomrisiko nach Behandlung 
von lokal begrenzten Prostatakarzinomen mit Kohlenstoffionen 
möglicherweise niedriger als nach Photonenbestrahlung. Strahlenther. Onkol. 195, 1033-1035 (2019)
Kundrát, P. et al. Individual variability in doses to contralateral breast from tangential breast-cancer radiotherapy follows from variations in minimum breast distance. Strahlenther. Onkol. 195, S82-S82 (2019)
Nguyen, L. ; Schilling, D. ; Dobiasch, S. ; Schmid, T.E. & Combs, S.E. Radioresistant pancreatic cancer cell lines show lower levels of reactive oxygen species and higher DNA repair capacity. Strahlenther. Onkol. 195, S164-S164 (2019)
Osterode, E.* et al. Evaluation of CD44v6 targeting strategies in HNSCC. Strahlenther. Onkol. 195, S176-S176 (2019)
Peeken, J.C. et al. Deep learning derived tumor infiltration maps for personalized target definition in Glioblastoma radiotherapy. Strahlenther. Onkol. 195, S114-S114 (2019)
Piehlmaier, D. et al. In-vitro and in-vivo characterization of a glioblastoma cell line panel. Strahlenther. Onkol. 195, S63-S64 (2019)
Sahay, J.* ; Schilling, D. ; Combs, S.E. & Gehrmann, M.* Exosomes from mistletoe extract treated breast cancer cells to stimulate immune cells. Strahlenther. Onkol. 195, S148-S148 (2019)
Scharl, S.* et al. Cavity volume changes after surgery of abrain metastasisconsequences for stereotactic radiation therapy. Strahlenther. Onkol. 195, 207-217 (2019)
Schilling, D. ; Wank, M. ; Reindl, J.* ; Schmid, T.E. & Combs, S.E. Development of a cell culture system for irradiation with high LET alpha particles under hypoxic conditions. Strahlenther. Onkol. 195, S90-S90 (2019)
Schmal, Z.* et al. DNA damage accumulation during fractionated low-dose radiation compromises hippocampal neurogenesis. Strahlenther. Onkol. 195, S90-S90 (2019)
Schmid, T.E. et al. Biological interaction of ionizing irradiation with a static magnetic field (SMF). Strahlenther. Onkol. 195, S89-S89 (2019)
Schnoeller, L.* et al. In-depth characterization of radiation response in a human glioblastoma cell line panel. Strahlenther. Onkol. 195, S120-S121 (2019)
Schötz, U. et al. Inherent resistance of head and neck tumors: Cellular senescence and associated cyokine production as key mechanisms in vitro and in vivo. Strahlenther. Onkol. 195, S76-S76 (2019)
Schrickel, F. et al. The individual invasive properties of patient-derived primary GBM cells. Strahlenther. Onkol. 195, S168-S169 (2019)
Siegmann, A. et al. New insights into dose-rate effects (FLASH) on clonogenic cell survival of tumor and normal cell lines. Strahlenther. Onkol. 195, S174-S175 (2019)
Simonetto, C. et al. Longitudinal atherosclerotic changes in patients with hypopharyngeal carcinoma after radio (Chemo) therapy. Strahlenther. Onkol. 195, S128-S128 (2019)
Straube, C. ; Shiban, E.* ; Meyer, B.* & Combs, S.E. Radiochirurgie und operative neurovaskuläre Dekompression annähernd gleichwertig beider Behandlung von Trigeminusneuralgien. Strahlenther. Onkol. 195, 688-690 (2019)
Unger, K. et al. Validation of a 4-miRNA prognosticator allowing for improved risk stratification of glioblastoma patients in combination with MGMT promoter methylation status. Strahlenther. Onkol. 195, S63-S63 (2019)
Vogel, M.M. et al. Early and late toxicity profiles of patients receiving immediate postoperative radiotherapy versus salvage radiotherapy for prostate cancer after prostatectomy. Strahlenther. Onkol. 195, 131-144 (2019)
Vogel, M.M.E.* et al. Development of a prognostic Risk Classification for biochemical Recurrence after PSMA-PET-based Radiotherapy in Patients with oligometastatic Prostate Cancer. Strahlenther. Onkol. 195, S30-S31 (2019)
Voglhuber, T.* ; Kessel, K.A. ; Oechsner, M.* & Combs, S.E. Patterns of care and outcome analysis of stereotactic radiotherapy for patients with adrenal metastases. Strahlenther. Onkol. 195, S39-S39 (2019)
Wagenblast, S.* et al. CT-based dose recalculations in head and neck cancer radiotherapy: Comparison of daily dose recalculations to less time-consuming approaches. Strahlenther. Onkol. 195, 475-481 (2019)
Waltenberger, M.* et al. 18F-FET PET MRI / CT in glioblastoma Rrlapse - contribution to target volume definition and association of tracer uptakes with survival. Strahlenther. Onkol. 195, S115-S115 (2019)
Wintergerst, L. et al. A 16q24.3 4-gene mRNA signature predicts outcome in radio(chemo)therapy-treated head and neck squamous cell carcinoma. Strahlenther. Onkol. 195, S24-S25 (2019)
Borm, K.J.* et al. Prognostic factors in stereotactic body radiotherapy of lung metastases. Strahlenther. Onkol. 194, 886-893 (2018)
Diehl, D.* et al. Adjuvant radiation after spinal instrumentation in metastatic bone disease: The potential benefit of carbon pedicel screws in target delineation in RT treatment planning . Strahlenther. Onkol. 194, 1 (2018)
Dobiasch, S.* ; Goerig, N.L.* ; Fietkau, R.* & Combs, S.E. Essential role of radiation therapy for the treatment of pancreatic cancer. Strahlenther. Onkol. 194, 185–195 (2018)
Dobiasch, S. et al. MRI-based high-precision irradiation in an orthotopic pancreatic tumor mouse model: A treatment planning study. Strahlenther. Onkol. 194, 994-952 (2018)
Issels, R.* et al. Regional hyperthermia and immuno-oncology. Strahlenther. Onkol. 194, 483-484 (2018)
Kessel, K.A. ; Klein, E.K.* ; Hack, C.C.* & Combs, S.E. Complementary medicine in radiation oncology: German health care professionals’ current qualifications and therapeutic methods. Strahlenther. Onkol. 194, 904-910 (2018)
Münch, S.* et al. Perioperative chemotherapy vs. neoadjuvant chemoradiation in gastroesophageal junction adenocarcinoma. A population-based evaluation of the Munich Cancer Registry. Strahlenther. Onkol. 194, 125-135 (2018)
Peeken, J.C.* et al. Semantic imaging features predict disease progression and survival in glioblastoma multiforme patients. Strahlenther. Onkol. 194, 580-590 (2018)
Peeken, J.C.* et al. Treatment-related features improve machine learning prediction of prognosis in soft tissue sarcoma patients. Strahlenther. Onkol. 194, 824-834 (2018)
Schiller, K.* & Combs, S.E. Einsatz alternativer Behandlungsmethoden bei Krebserkrankungen und Auswirkungen auf das Überleben. Strahlenther. Onkol. 194, 870-871 (2018)
Simonetto, C. et al. Exposure of remote organs and associated cancer risks from tangential and multi-field breast cancer radiotherapy. Strahlenther. Onkol. 195, 32-42 (2018)
Arend, F.* ; Duma, M.N. ; Combs, S.E. & Oechsner, M.* Volume regression of cervical carcinoma in T2-weighted MRI under percutaneous radio-chemotherapy. Strahlenther. Onkol. 193, S164-S164 (2017)
Asadpour, R.* et al. Randomized study exploring the combination of radioTherapy with two types of acupuncture treatment (ROSETTA trial). Strahlenther. Onkol. 193, S172-S173 (2017)
Bihoi, G.A.* ; Kessel, K.A. ; Oechsner, M.* ; Duma, M.N.* & Combs, S.E. Influence of the dose applied to the cochlea during radiotherapy of the vestibular schwannoma and its effect on hearing preservation. Strahlenther. Onkol. 193, S133-S134 (2017)
Burger, K.* et al. Micro-channel radiotherapy with X-rays on a compact synchrotron. Strahlenther. Onkol. 193, S10-S11 (2017)
Combs, S.E. ; Kessel, C.* ; Trott, K.R.* ; Berberat, P.* & Atkinson, M.J. Students' expectations regarding work load, teaching format and interprofessional acitivies in an International Master of Science (MSc) course in radiation biology. Strahlenther. Onkol. 193, S116-S116 (2017)
Combs, S.E. et al. Moving second courses of radiotherapy forward: early re-irradiation after surgical resection for recurrent gliomas improves efficacy with excellent tolerability. Strahlenther. Onkol. 193, S52-S53 (2017)
Corradini, S.* et al. Left-sided breast cancer and risks of secondary lung cancer and ischemic heart disease. Strahlenther. Onkol. 194, 196-205 (2017)
Corradini, S.* et al. Left-sided breast cancer and risks of secondary lung cancer and ischemic heart disease-Effects of modern radiotherapy techniques (vol 194, pg 196, 2017). Strahlenther. Onkol. 194, 273-274 (2017)
Devecka, M.* et al. Acute hematological toxicities in patients treated with (cranio)-spinal irradiation according to treatment technique and prior chemotherapy use. Strahlenther. Onkol. 193, S155-S156 (2017)
Diehl, C.D.* ; Peeken, J.C.* ; Specht, H.M.* ; Habermehl, D. & Combs, S.E. Serum levels and outcome correlation of S100 and neuron pecific enolase (NSE) during radiation therapy of brain metastases. Strahlenther. Onkol. 193, S180-S180 (2017)
Diehl, C.D.* et al. Presurgical navigated transcranial motorcortex mapping data in radiotherapy planning: Motorcortex sparing in the treatment of brain tumors. Strahlenther. Onkol. 193, S40-S40 (2017)
Dobiasch, S.* et al. BioXmark for high-precision radiotherapy in an orthotopic pancreatic tumor mouse model: Experiences with a liquid fiducial marker. Strahlenther. Onkol. 193, 1039-1047 (2017)
Dobiasch, S.* ; Kampfer, S.* ; Burkhardt, R. ; Wilkens, J.J. & Combs, S.E. Use of the liquid fiducial marker BioXmark for high-precision radiotherapy of a tumor mouse model. Strahlenther. Onkol. 193, S37-S38 (2017)
Dombrowsky, A. et al. Setup for tumor growth delay studies in small animals for low energy x-rays and small irradiation fields. Strahlenther. Onkol. 193, S54-S54 (2017)
Fischer, H.* et al. The complaint profile of meningioma-patients after Usage of [68Ga] DOTANOC-PET in radiation treatment planning. Strahlenther. Onkol. 193, S167-S167 (2017)
Gerhardt, S.* ; Duma, M.N. ; Wilkens, J.J. ; Combs, S.E. & Oechsner, M.* Evaluation of patient positioning with exactrac system for the irradiation of intracranial tumors. Strahlenther. Onkol. 193, S148-S148 (2017)
Gkika, E.* et al. Interobserver variability in target volume delineation of hepatocellular carcinoma: An analysis of the working group “Stereotactic Radiotherapy” of the German Society for Radiation Oncology (DEGRO). Strahlenther. Onkol. 193, 823–830 (2017)
Hofmeister, A.* et al. Reduction of the lung dose in stereotactic irradiation of lung tumors due to respiratory gating. Strahlenther. Onkol. 193, S145-S145 (2017)
Kessel, C.* ; Atkinson, M.J. ; Trott, K.* ; Berberat, P.* & Combs, S.E. Quality assurance in higher education - traditional and innovative student feedback methods in the MSc Radiation Biology Program at the School of Medicine of the Technical University of Munich (TUM). Strahlenther. Onkol. 193, S170-S170 (2017)
Kessel, K.A. et al. Fractionated vs. single-fraction stereotactic radiotherapy in patients with vestibular schwannoma: Hearing preservation and patients’ self-reported outcome based on an established questionnaire. Strahlenther. Onkol. 193, 192-199 (2017)
Kessel, K.A. et al. Erratum to: Fractionated vs. single-fraction stereotactic radiotherapy in patients with vestibular schwannoma: Hearing preservation and patients’ self-reported outcome based on an established questionnaire. Strahlenther. Onkol. 193:171 (2017)
Kessel, K.A. et al. High-precision radiotherapy for meningiomas: Long-term results and patient-reported outcome (PRO). Strahlenther. Onkol. 193, 921-930 (2017)
Kessel, K.A. ; Vogel, M.M. ; Schmidt-Graf, F.* & Combs, S.E. An only survey seeking healthcare professionals' opinion on mobile apps in oncology. Strahlenther. Onkol. 193, S168-S168 (2017)
Kessel, K.A. et al. Further development of an established prognostic score after re-irradiation of recurrent glioma. Strahlenther. Onkol. 193, S95-S96 (2017)
Kessel, K.A. et al. Mobile applications in oncology - a survey on evaluating the patient acceptance in a German Oncology Center: Final analysis. Strahlenther. Onkol. 193, S23-S24 (2017)
Kirstein, A.* et al. Change in resection cavity volume after surgery and local stereotactic radiotherapy of brain metastases. Strahlenther. Onkol. 193, S156-S157 (2017)
Koelemenoglu, L.* ; Schilling, D. ; Reitz, S.* & Combs, S.E. Selenium and zinc blood levels during radiation therapy the prospective, non-interventional SELINK-study. Strahlenther. Onkol. 193, S39-S39 (2017)
Lettner, S.* ; Kessel, K.A. & Combs, S.E. Complementary and alternative medicine in radiation oncology: Survey of patients’ attitudes. Strahlenther. Onkol. 193, 419-425 (2017)
Maihoefer, C.* et al. The influence of anemia, nicotine abuse and co-morbidities in patients with adjuvant radio(chemo)therapy in HNSCC. Strahlenther. Onkol. 193, S147-S148 (2017)
Martin, F.* et al. ALDH1A1 expression enhances migration and radioresistance of glioblastoma cells. Strahlenther. Onkol. 193, S166-S166 (2017)
Muench, S.* et al. Comparison of perioperative chemotherapy and neoadjuvant chemoradiation in patients with adenocarcinoma of the gastro-esophageal junction: A population-based evaluation of the Munich Cancer Registry. Strahlenther. Onkol. 193, S33-S34 (2017)
Niyazi, M.* et al. Independent validation of a prognostic 4-miRNA signature in de novo glioblastoma. Strahlenther. Onkol. 193, S52-S52 (2017)
Oechsner, M.* et al. Interobserver variability of patient positioning using four different CT datasets for image registration in lung stereotactic body radiotherapy. Strahlenther. Onkol. 193, 831–839 (2017)
Oechsner, M.* et al. Inter-observer-comparison concerning the effects of the reference-CT on image registration with 3D cone beam CTs in lung stereotaxy. Strahlenther. Onkol. 193, S120-S120 (2017)
Ott, J. et al. Characterization of migration of four mammary carcinoma cell lines after irradiation. Strahlenther. Onkol. 193, S141-S142 (2017)
Peeken, J.C.* ; Nüsslin, F.* & Combs, S.E. “Radio-oncomics”: The potential of radiomics in radiation oncology. Strahlenther. Onkol. 193, 767–779 (2017)
Peeken, J.C.* ; Diehl, C.* ; Combs, S.E. & Duma, M.N.* Evaluation of IMRT-based simultaneous integrated protection (SIP) concepts in re-irradiations of bone metastases. Strahlenther. Onkol. 193, S129-S129 (2017)
Peeken, J.C.* ; Hesse, J.* ; Kessel, K.* ; Nuesslin, F.* & Combs, S.E. Creation of a joint prognostic model by combining clinical and qualitative imaging features for Glioblastoma Multiforme patients. Strahlenther. Onkol. 193, S51-S51 (2017)
Piehlmaier, D. et al. In-vitro and in-vivo characterization of a glioblastoma cell line panel. Strahlenther. Onkol. 193, S154-S154 (2017)
Radtke, A.* et al. Hypoxia-induced radio-resistance in glioblastoma cells as a function of the LET. Strahlenther. Onkol. 193, S152-S153 (2017)
Ruehle, P.F.* et al. GLIO-CMV-01: Identification of immune biomarkers for CMV related encephalitis during standard brain radiotherapy. Strahlenther. Onkol. 193, S50-S50 (2017)
Sage, E.K.* et al. Effects of definitive and salvage radiotherapy on the distribution of lymphocyte subpopulations in prostate cancer patients. Strahlenther. Onkol. 193, 648–655 (2017)
Sage, E.K.* et al. Effects of local radiotherapy on the composition of lymphocyte subpopulations in prostate and breast cancer patients. Strahlenther. Onkol. 193, S180-S181 (2017)
Scharl, S.* ; Straube, C.* ; Meyer, B.* ; Schmidt-Graf, F.* & Combs, S.E. Critical consideration of the European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas. Strahlenther. Onkol. 193, 984-988 (2017)
Schmid, T.E. et al. Submicrometer focusing of low LET protons - understanding the RBE of heavy ion irradiation. Strahlenther. Onkol. 193, S104-S105 (2017)
Schneider, L. et al. Subgroups of HPV-positive and HPV-negative head and neck squamous cell carcinoma differing in global copy number changes and prognosis. Strahlenther. Onkol. 193, S149-S149 (2017)
Schoetz, U.* et al. Increased CD44v6 expression confers radioresistance in subsets of HNSCC. Strahlenther. Onkol. 193, S85-S85 (2017)
Straube, C.* & Combs, S.E. Kombination von Strahlentherapie mit Temozolomid bei über 65-jährigen Glioblastompatienten. Strahlenther. Onkol. 193, 510-512 (2017)
Straube, C.* et al. Re-irradiation after gross total resection of recurrent glioblastoma: Spatial pattern of recurrence and a review of the literature as a basis for target volume definition. Strahlenther. Onkol. 193, 897–909 (2017)
Straube, C.* et al. Moving Re-Irradition forward: Generation of target volume guidelines in patients with recurrent glioblastoma following gross total resection. Strahlenther. Onkol. 193, S100-S101 (2017)
Tufman, A. et al. Clinical relevance of the M1b and M1c descriptors from the proposed TNM 8 classification of lung cancer. Strahlenther. Onkol. 193, 392-401 (2017)
Vogel, M.M. ; Kessel, K.A. & Combs, S.E. Mobile applications in oncology: App-assisted treatment and research. Strahlenther. Onkol. 193, S171-S171 (2017)
Wunderlich, R. et al. Irradiated HPV+ head and neck cancer cells induce an interferon related gene expression in various innate immune cell subtypes. Strahlenther. Onkol. 193, S84-S84 (2017)
Zahnbrecher, E.* et al. Reduced acute side effects by proton mini beam radiation therapy in the mouse ear model. Strahlenther. Onkol. 193, S171-S171 (2017)
Adeberg, S.* et al. Intensity-modulated proton therapy, volumetric-modulated arc therapy, and 3D conformal radiotherapy in anaplastic astrocytoma and glioblastoma : A dosimetric comparison. Strahlenther. Onkol. 192, 770-779 (2016)
Combs, S.E. ; Nüsslin, F.* & Wilkens, J.J. Individualized radiotherapy by combining high-end irradiation and magnetic resonance imaging. Strahlenther. Onkol. 192, 209-215 (2016)
Combs, S.E. Protonentherapie bei Kindern mit Medulloblastom bei akzeptablen Nebenwirkungen ähnlich erfolgreich wie Photonentherapie. Strahlenther. Onkol. 192, 498-499 (2016)
Combs, S.E. ; Schmidt-Graf, F.* & Meyer, B.* Bessere Prognose von Low-grade-Gliomen durch Kombination von Bestrahlung, Procarbazin, CCNU und Vincristin. Strahlenther. Onkol. 192, 672-674 (2016)
Harrabi, S.B.* et al. Dosimetric advantages of proton therapy over conventional radiotherapy with photons in young patients and adults with low-grade glioma. Strahlenther. Onkol. 192, 759-769 (2016)
Münch, S.* et al. Comparison of dosimetric parameters and toxicity in esophageal cancer patients undergoing 3D conformal radiotherapy or VMAT. Strahlenther. Onkol. 192, 722-729 (2016)
Specht, H.M.* et al. HFSRT of the resection cavity in patients with brain metastases. Strahlenther. Onkol. 192, 368-376 (2016)
Vaupel, P.* & Multhoff, G. Adenosine can thwart antitumor immune responses elicited by radiotherapy : Therapeutic strategies alleviating protumor ADO activities. Strahlenther. Onkol. 192, 279-287 (2016)
Combs, S.E. et al. Clinical outcome after high-precision radiotherapy for skull base meningiomas: Pooled data from three large German Centers of Radiation Oncology. Strahlenther. Onkol. 191, S38 (2015)
Dittmar, J.O.* et al. Changes of the meningioma specific chromosomal aberration after radiotherapy with photons or carbon ions. Strahlenther. Onkol. 191, S146 (2015)
Dittmar, J.O.* et al. The [Ga-68]-DOTA-D Phe 1-3Tyr3-Octreotide (DOTATOC)- based radiotherapy planning leads to improved organ preservation risk at the proton- radiotherapy of intracranial meningiomas. Strahlenther. Onkol. 191, S151-S152 (2015)
Dittmar, J.O.* et al. An automated treatment planning leads to a significant time savings during radiosurgical treatment multiple brain metastases - an evaluation of the tools, brain metastases for brainlab. Strahlenther. Onkol. 191, S154 (2015)
Gunther, S.* et al. Development of a novel LipHsp70 ELISA for screening of exosomal Hsp70 in the blood of NSCLC patients. Strahlenther. Onkol. 191, S72-S73 (2015)
Hess J. et al. Signalling networks associated with FancA mediated radioresistance in cells of head and neck squamous cell carcinoma. Strahlenther. Onkol. 191, S77 (2015)
Kuger, S. et al. The influence of FancA overexpression on radioresistance in oral keratinocytes and HNSCC cells. Strahlenther. Onkol. 191, S90 (2015)
Lettner, S.* ; Kessel, K.A.* & Combs, S.E. Complementary medical teatment as part of the radio oncology therapy - questionnaire for the evaluation of acceptance and of dealing with the range of therapies in a large German department for radiation oncology. Strahlenther. Onkol. 191, S13 (2015)
Maihoefer, C.* et al. Implementation of a clinical database for the evaluation of the treatment results of patients with HNSCC - outcome of 195 monocentrically adjuvant treated patients from 2008 to 2012. Strahlenther. Onkol. 191, S119-S120 (2015)
Orth, M.* ; Unger, K. ; Belka, C.* & Lauber, K.* Paclitaxel-mediated radiosensitization is based on aneuploidization and depends on high expression levels of Aurora A kinase and TPX2. Strahlenther. Onkol. 191, S81 (2015)
Penterling, C.* ; Wilke, C. ; Unger, K. & Friedl, A.A. Analysis of radiation-induced transcriptome alterations in a p53-compromised cell line. Strahlenther. Onkol. 191, S76 (2015)
Schneider, L. et al. Identification and validation of predictive markers in head and neck squamous cell carcinomas. Strahlenther. Onkol. 191, S86-S87 (2015)
Schoetz, U.* et al. Inherent radioresistance of head and neck squamous cell carcinoma cells: Principal component analysis identifies cellular senescence as a crucial driver. Strahlenther. Onkol. 191, S121 (2015)
Specht, H.M.* et al. Local hypofractionated stereotactic radiotherapy (HFSRT) after surgical resection of brain metastasis. Strahlenther. Onkol. 191, S37 (2015)
Specht, H.M.* et al. Evaluation of treatment concepts and indications for Fast Neutron Therapy (FNT) using reactor fission neutrons. Strahlenther. Onkol. 191, S66 (2015)
Hess J. et al. FANCA overexpression confers radioresistance to cells of head and neck squamous cell carcinoma. Strahlenther. Onkol. 190, 29 (2014)
Maroschik, B.* et al. Radiation-induced alterations of histone post-translational modification levels in lymphoblastoid cell lines. Strahlenther. Onkol. 190, 81 (2014)
Michna, A. et al. Identification of molecular targets and signalling networks that influence sensitivity to ionising radiation. Strahlenther. Onkol. 190, 77 (2014)
Multhoff, G. & Trott, K.-R.* Screening von Genpolymorphismen verbessert die Vorhersage der Strahlentoxizität nicht. Strahlenther. Onkol. 189, 91-92 (2013)
Multhoff, G. ; Gaipl, U.S.* & Niedermann, G.* Die Rolle der Strahlentherapie bei der Induktion von Antitumor-Immunantworten. Strahlenther. Onkol. 188, 312-315 (2012)
Schilling, D. et al. Basal HIF-1α expression levels are not predictive for radiosensitivity of human cancer cell lines. Strahlenther. Onkol. 188, 353-358 (2012)
Schulte, T.L.* ; Nekolla, E.A.* & Wick, R.R. Langzeituntersuchung zum Risiko maligner Erkrankungen nach intravenöser Behandlung des Morbus Bechterew mit Radium-224. Strahlenther. Onkol. 185, 549-556 (2009)
Milani, V.* et al. Radiochemotherapy in combination with regional hyperthermia in preirradiated patients with recurrent rectal cancer. Strahlenther. Onkol. 184, 163-168 (2008)
Michailov, M.C. ; Neu, E. ; Tempel, K. ; Hölzl, H. & Breiter, N. Influence of X-irradiation on the Motor Activity of the Rat Urinary Bladder in Vitro and in Vivo. Strahlenther. Onkol. 167, 311-318 (1991)
Michailov, M.C. ; Neu, E. ; Tempel, K.H. ; Hölzl, H. & Breiter, N. Influence of X-irradiation on the motor activity of rat urinary bladder in vitro and in vivo. Strahlenther. Onkol. 167, 311-318 (1991)
Sassy, T. ; Breiter, N. & Trott, K.-R. Die Wirkung von Tetrachlordecaoxid (TCDO) auf den chronischen Strahlenschaden am Rattenkolon. Strahlenther. Onkol. (1990)
Burger, G. Cytometry, a Possible Tool for Assessment of Tumor Response. Strahlenther. Onkol. 165, 291-293 (1989)
Burger, G. ; Wambersie, A. ; Breit, A. ; Bewley, D. & Scherer, E. Advances in radiobiology and neutron radiotherapy. Strahlenther. Onkol. 165, 259-356 (1989)
Burger, G.T. Cytometry, a possible tool for assessment of tumor response. Strahlenther. Onkol. 165, 291-293 (1989)
Kummermehr, J. et al. Biological Effectiveness of Neutrons and pi-mesons in Gut, Bone, and Transplantable Tumours. Strahlenther. Onkol. 165, 276-282 (1989)
Michailov, M.C. ; Amelung, H. ; Welscher, U.E. & Neu, E. Reaktionen der isolierten Rattenaorta auf Röntgenstrahlung. Strahlenther. Onkol. 165, 860-865 (1989)
Ries, G. et al. First Experiences with Fission Neutrons in the Radiation Therapy of Cancer Patients. Strahlenther. Onkol. 165, 302-305 (1989)
Breiter, N. ; Sassy, T. ; Trott, K.R. & Unsöld, E. Die endoskopische Verlaufskontrolle und deren histologische Korrelation des chronischen Strahlenschadens am Enddarm der Ratte. Strahlenther. Onkol. 164, 674-680 (1988)
Hagen, U. ; Guttenberger, R. & Kummermehr, J. Intrazelluläre Erholung - Grundlagen der Hyperfraktionierung. Strahlenther. Onkol. 164, 653-656 (1988)
Hagen, U. ; Guttenberger, R. & Kummermehr, J.C. Intracellular recovery--basis of hyperfractionation | Intrazelluläre Erholung--Grundlage der Hyperfraktionierung. Strahlenther. Onkol. 164, 653-656 (1988)
Michailov, M.C. ; Amelung, H. ; Welscher, U. & Neu, E. Reactions of isolated rat aorta to X-irradiation. Strahlenther. Onkol. (1988)
Issels, R.D. ; Nagele, A. ; Boning, B. ; Bourier, S. & Wilmanns, W. Thiol-compounds as thermosensitizer: Experimental results. Strahlenther. Onkol. 163, 420-421 (1987)
Chmelevsky, D. ; Kellerer, A.M. ; Spieß, H.F. & Mays, C.W. A proportional hazards analysis of bone sarcoma rates in German 244radium patients. Strahlenther. Onkol. 162, 32-37 (1986)
Englmeier, K.-H. ; Hecker, R. ; Hötzinger, H. & Thiel, H.J. Automatische kontursuche und Segmentierung von sonographischen transversalschnittbildern des Uterus hinsichtlich einer optimierten individuellen Isodosengestaltung bei Korpuskarzinomen. Strahlenther. Onkol. 161, 275-280 (1985)
Schachinger, L. ; Srivastava, A.K. ; Schippel, C. & Klöter, H. Effect of irradiated dib-cAMP on the tonic and phasic activity of human myometrium. Strahlenther. Onkol. 159, 358-365 (1983)
Eckerl, H. ; Thomasz, E. & Drexler, G.G. Ermittlung der effektiven äquivalentdosis bei der Gynakologischen Radiumtherapie. Strahlenther. Onkol. 158, 422-426 (1982)
Kummermehr, J.C. ; Fink, R. ; Preuss-Bayer, G. & Trott, K.R. Reoxygenierung in einem Transplantabelen fibrosakom der Maus. Strahlenther. Onkol. 157, 272-276 (1981)
Schraube, H. ; Koester, L. & Breit, A. Status report on neutron treatment planning for the rent-project. Strahlenther. Onkol. 157, 190-198 (1981)
Schmahl, W.G. ; Weber, L.W.D. & Kriegel, H. X-irradiation of mice in the early fetal period. I. Assessment of lasting CNS deficits developing mainly in the subsequent perinatal period. Strahlenther. Onkol. 155, 347-357 (1979)
Born, R. Die Abhänigkeit des Sauerstoffeffekts von der Dosisleistung. Strahlenther. Onkol. 154, 650-652 (1978)
Trott, K.R. Der Einfluss der Dosisleistung auf die therapeutische Wirkung von 60CO-Gammabestrahlung beim Adenokarzinom der Maus. Strahlenther. Onkol. 154, 656-658 (1978)
von Szczepanski, L. & Trott, K.R. Fraktionierte Radio-Hyperthermie-Behandlung transplantabler Adenokarzinome der Maus. Strahlenther. Onkol. 154, 653-655 (1978)
Hochhaeuser, E. Zum Gewebe- Luft- Verhältnis bei doppelseitiger Ganzkörperbestrahlung. Strahlenther. Onkol. 153, 820-824 (1977)
Müller, W.H. Predictibility of the stability constant of a radium cryptate by means of in vivo data from radioactive alkaline earthes. Strahlenther. Onkol. 153, 570-571 (1977)
Schmahl, W.G. ; Kriegel, H. & Ostertag, B. Missbildungen des ZNS fetaler Mäuse nach fraktionierter ganzkörper Röntgenbestrahlung. Topographische und quantitative mikrobiologische Charakterisierung. Strahlenther. Onkol. 153, 630-637 (1977)
Pohlit, W. Physikalische und biologische Grundlagen der Neutronentherapie. Strahlenther. Onkol. 145, 491-503 (1973)